MARKET

GOVX

GOVX

Geovax Labs Inc
NASDAQ
1.670
-0.090
-5.11%
After Hours: 1.710 +0.04 +2.40% 19:41 05/08 EDT
OPEN
1.780
PREV CLOSE
1.760
HIGH
1.800
LOW
1.461
VOLUME
560.17K
TURNOVER
--
52 WEEK HIGH
34.75
52 WEEK LOW
0.9631
MARKET CAP
4.83M
P/E (TTM)
-0.0746
1D
5D
1M
3M
1Y
5Y
1D
GeoVax Labs Announces Warrant Inducement and Financing Move
TipRanks · 1d ago
GeoVax enters warrant inducement for exercise of 501,144 existing warrants
PUBT · 1d ago
Weekly Report: what happened at GOVX last week (0427-0501)?
Weekly Report · 5d ago
Weekly Report: what happened at GOVX last week (0420-0424)?
Weekly Report · 04/27 09:39
Weekly Report: what happened at GOVX last week (0413-0417)?
Weekly Report · 04/20 09:38
GeoVax Labs price target lowered to $10 from $14 at Roth Capital
TipRanks · 04/17 15:35
GeoVax Labs Price Target Maintained With a $1.00/Share by D. Boral Capital
Dow Jones · 04/16 12:26
GeoVax Labs Is Maintained at Hold by D. Boral Capital
Dow Jones · 04/16 12:26
More
About GOVX
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines against infectious diseases and therapies for solid tumor cancers. Its lead clinical program is GEO-CM04S1, a COVID-19 vaccine, which is in three phase II clinical trials, being evaluated as a primary vaccine for immunocompromised patients, such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient; a booster vaccine in patients with chronic lymphocytic leukemia (CLL); and a COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology, the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin, having completed a multicenter Phase I/II clinical trial for advanced head and neck cancers. It is developing GEO-MVA, a vaccine targeting Mpox and smallpox. Its other product candidates include GEO-EM01-Z, GEO-EM01-S, GEO-MM01, GEO-ZM02 and others.

Webull offers Geovax Labs Inc stock information, including NASDAQ: GOVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GOVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GOVX stock methods without spending real money on the virtual paper trading platform.